Growing evidences indicate that PTHLH-producing cholangiocarcinoma (CHO) patients suffer from humoral hypercalcemia of malignancy [7–9], but litter is known regarding PTHLH’s effect on ICC cells growth. This evidence concerns the gene PTHLH and intrahepatic cholangiocarcinoma.